{"id":"NCT00653068","sponsor":"Children's Oncology Group","briefTitle":"Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System","officialTitle":"Treatment of Atypical Teratoid/Rhabdoid Tumors (AT/RT) of the Central Nervous System With Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-02-10","primaryCompletion":"2016-09-27","completion":"2024-03-31","firstPosted":"2008-04-04","resultsPosted":"2017-02-13","lastUpdate":"2024-04-23"},"enrollment":70,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Childhood Atypical Teratoid/Rhabdoid Tumor"],"interventions":[{"type":"RADIATION","name":"3-Dimensional Conformal Radiation Therapy","otherNames":["3-dimensional radiation therapy","3D Conformal","3D CONFORMAL RADIATION THERAPY","3D CRT","3D radiotherapy","3D-CRT","Conformal Therapy","Radiation Conformal Therapy","Radiation, 3D Conformal","Three dimensional external beam radiation therapy (procedure)"]},{"type":"PROCEDURE","name":"Autologous Hematopoietic Stem Cell Transplantation","otherNames":["AHSCT","Autologous","Autologous Hematopoietic Cell Transplantation","Autologous Stem Cell Transplant","Autologous Stem Cell Transplantation","Stem Cell Transplantation, Autologous"]},{"type":"DRUG","name":"Carboplatin","otherNames":["Blastocarb","Carboplat","Carboplatin Hexal","Carboplatino","Carboplatinum","Carbosin","Carbosol","Carbotec","CBDCA","Displata","Ercar","JM-8","JM8","Nealorin","Novoplatinum","Paraplatin","Paraplatin AQ","Paraplatine","Platinwas","Ribocarbo"]},{"type":"DRUG","name":"Cisplatin","otherNames":["Abiplatin","Blastolem","Briplatin","CDDP","Cis-diammine-dichloroplatinum","Cis-diamminedichloridoplatinum","Cis-diamminedichloro Platinum (II)","Cis-diamminedichloroplatinum","Cis-dichloroammine Platinum (II)","Cis-platinous Diamine Dichloride","Cis-platinum","Cis-platinum II","Cis-platinum II Diamine Dichloride","Cismaplat","Cisplatina","Cisplatinum","Cisplatyl","Citoplatino","Citosin","Cysplatyna","DDP","Lederplatin","Metaplatin","Neoplatin","Peyrone's Chloride","Peyrone's Salt","Placis","Plastistil","Platamine","Platiblastin","Platiblastin-S","Platinex","Platinol","Platinol- AQ","Platinol-AQ","Platinol-AQ VHA Plus","Platinoxan","Platinum","Platinum Diamminodichloride","Platiran","Platistin","Platosin"]},{"type":"DRUG","name":"Cyclophosphamide","otherNames":["(-)-Cyclophosphamide","2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate","Asta B 518","B-518","Carloxan","Ciclofosfamida","Ciclofosfamide","Cicloxal","Clafen","Claphene","CP monohydrate","CTX","CYCLO-cell","Cycloblastin","Cycloblastine","Cyclophospham","Cyclophosphamid monohydrate","Cyclophosphamide Monohydrate","Cyclophosphamidum","Cyclophosphan","Cyclophosphane","Cyclophosphanum","Cyclostin","Cyclostine","Cytophosphan","Cytophosphane","Cytoxan","Fosfaseron","Genoxal","Genuxal","Ledoxina","Mitoxan","Neosar","Revimmune","Syklofosfamid","WR- 138719","WR-138719"]},{"type":"DRUG","name":"Etoposide","otherNames":["Demethyl Epipodophyllotoxin Ethylidine Glucoside","EPEG","Lastet","Toposar","Vepesid","VP 16","VP 16-213","VP 16213","VP-16","VP-16-213","VP16"]},{"type":"BIOLOGICAL","name":"Filgrastim","otherNames":["Filgrastim Biosimilar Filgrastim-sndz","Filgrastim Biosimilar Tbo-filgrastim","Filgrastim XM02","Filgrastim-aafi","Filgrastim-ayow","Filgrastim-sndz","G-CSF","Granix","Neupogen","Neutroval","Nivestym","r-metHuG-CSF","Recombinant Methionyl Human Granulocyte Colony Stimulating Factor","Releuko","rG-CSF","Tbo-filgrastim","Tevagrastim","XM02","Zarxio"]},{"type":"OTHER","name":"Laboratory Biomarker Analysis","otherNames":[]},{"type":"DRUG","name":"Leucovorin Calcium","otherNames":["Adinepar","Calcifolin","Calcium (6S)-Folinate","Calcium Folinate","Calcium Leucovorin","Calfolex","Calinat","Cehafolin","Citofolin","Citrec","Citrovorum Factor","Cromatonbic Folinico","Dalisol","Disintox","Divical","Ecofol","Emovis","Factor, Citrovorum","Flynoken A","Folaren","Folaxin","FOLI-cell","Foliben","Folidan","Folidar","Folinac","Folinate Calcium","Folinic acid","Folinic Acid Calcium Salt Pentahydrate","Folinoral","Folinvit","Foliplus","Folix","Imo","Lederfolat","Lederfolin","Leucosar","leucovorin","Rescufolin","Rescuvolin","Tonofolin","Wellcovorin"]},{"type":"DRUG","name":"Methotrexate","otherNames":["Abitrexate","Alpha-Methopterin","Amethopterin","Brimexate","CL 14377","CL-14377","Emtexate","Emthexat","Emthexate","Farmitrexat","Fauldexato","Folex","Folex PFS","Lantarel","Ledertrexate","Lumexon","Maxtrex","Medsatrexate","Metex","Methoblastin","Methotrexate LPF","Methotrexate Methylaminopterin","Methotrexatum","Metotrexato","Metrotex","Mexate","Mexate-AQ","MTX","Novatrex","Rheumatrex","Texate","Tremetex","Trexeron","Trixilem","WR-19039"]},{"type":"DRUG","name":"Thiotepa","otherNames":["1,1',1''-Phosphinothioylidynetrisaziridine","Girostan","N,N', N''-Triethylenethiophosphoramide","Oncotiotepa","STEPA","Tepadina","TESPA","Tespamin","Tespamine","Thio-Tepa","Thiofosfamide","Thiofozil","Thiophosphamide","Thiophosphoamide","Thiophosphoramide","Thiotef","Tifosyl","TIO TEF","Tio-tef","Triethylene Thiophosphoramide","Triethylenethiophosphoramide","Tris(1-aziridinyl)phosphine sulfide","TSPA","WR 45312"]},{"type":"DRUG","name":"Vincristine Sulfate","otherNames":["Kyocristine","Leurocristine Sulfate","Leurocristine, sulfate","Oncovin","Vincasar","Vincosid","Vincrex","Vincristine, sulfate"]}],"arms":[{"label":"Arm I (chemotherapy, autologous PBSC, 3D-CRT)","type":"EXPERIMENTAL"},{"label":"Arm II (chemotherapy, 3D-CRT, autologous PBSC)","type":"EXPERIMENTAL"}],"summary":"This phase III trial studies the side effects of combination chemotherapy, 3-dimensional conformal radiation therapy, and an autologous peripheral blood stem cell transplant, and to see how well they work in treating young patients with atypical teratoid/rhabdoid tumor of the central nervous system. Giving high-dose chemotherapy before an autologous peripheral blood stem cell transplant stops the growth of cancer cells by stopping them from dividing or killing them. Giving colony-stimulating factors, such as G-CSF, helps stem cells move from the bone marrow to the blood so they can be collected and stored. Chemotherapy or radiation therapy is then given to prepare the bone marrow for the stem cell transplant. The stem cells are then returned to the patient to replace the blood-forming cells that were destroyed by the chemotherapy or radiation therapy.","primaryOutcome":{"measure":"Event-free Survival","timeFrame":"Up to 4 years after study enrollment","effectByArm":[{"arm":"Stratum I","deltaMin":0.3401,"sd":null},{"arm":"Stratum III","deltaMin":0.45,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":18,"exclusionCount":null},"locations":{"siteCount":94,"countries":["United States","Australia","Canada"]},"refs":{"pmids":["39515374","32730180"],"seeAlso":["https://nctn-data-archive.nci.nih.gov/"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":57},"commonTop":["Neutrophil count decreased","Platelet count decreased","White blood cell decreased","Lymphocyte count decreased","Infections and infestations - Other, specify"]}}